neoadjuvant - Robuta Search

https://www.vumc.org/pietenpol-lab/publication/transcriptome-meta-analysis-triple-negative-breast-cancer-response-neoadjuvant Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy.... triple negative breast cancer meta analysis https://www.mdpi.com/2077-0383/11/3/812 Could Total Neoadjuvant Therapy Followed by Surgical Resection Be the New Standard of Care in... Background. Total neoadjuvant therapy (TNT), intended as induction chemotherapy (IC) followed by radio-chemotherapy (RCT), has been taking hold in the... https://elifesciences.org/articles/91737/figures Figures and data in Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and... Stereotactic body radiotherapy combined with immunotherapy and chemotherapy in neoadjuvant setting exhibited a promising anti-tumor activity and an acceptable... https://www.scirp.org/journal/PaperInformation?PaperID=25230 Sentinel Lymph Node Biopsy Prior to Neoadjuvant Chemotherapy: A Series of 89 Patients Purpose: There are still un-responded questions concerning the type of and the timing of axillary procedures that has to be performed in association with... sentinel lymph node biopsy https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2018.00872/full Frontiers | Comparative Effectiveness of Neoadjuvant Treatments for Resectable Gastroesophageal... Background Several neoadjuvant treatments are available for patients with resectable gastroesophageal cancer. We did a Bayesian network meta-analysis (NMA) t... comparative effectiveness treatments for frontiers neoadjuvant resectable https://www.rti.org/publication/neoadjuvant-systemic-therapy-breast-cancer-factors-influencing-surgeons-referrals Neoadjuvant Systemic Therapy for Breast Cancer | RTI Surgeons' decision to refer for NST is strongly driven by surgical management goals. Anatomicopathologic factors are more influential than tumor phenotype.... systemic therapy breast cancer neoadjuvant rti https://pmc.ncbi.nlm.nih.gov/articles/PMC7311547/ Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the... Short-term fasting protects tumor-bearing mice against the toxic effects of chemotherapy while enhancing therapeutic efficacy. We randomized 131 patients with... fasting mimicking diet https://www.mdpi.com/2077-0383/13/6/1684 Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal... Background: Circulating tumor DNA (ctDNA) is extracellular DNA released by tumors and has been proposed as a marker of residual disease as well as a predictor... circulating tumor dna https://www.preprints.org/manuscript/202505.0178 Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable... Historically, systemic therapy for resectable non-small cell lung cancer (NSCLC) has been associated with modest impact in overall survival. Current treatment... early stage neoadjuvant perioperative immunotherapy surgically https://www.spandidos-publications.com/10.3892/mmr.2017.7555?text=fulltext High expression of endoglin in primary breast cancer may predict response to neoadjuvant... Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery. primary breast cancer https://www.mdanderson.org/newsroom/neoadjuvant-combination-immunotherapy-improves-outcomes-for-earl.h00-159458478.html Neoadjuvant combination immunotherapy improves outcomes for early stage non-small cell lung cancer... The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell... https://www.scirp.org/journal/paperinformation?paperid=58399 Multiparameteric PET-MR Assessment of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced... Purpose: Patients with locally advanced rectal cancer (LARC) achieving pathologic complete response (pCR) to neoadjuvant chemoradiotherapy (CRT) have... pet mr https://www.frontiersin.org/research-topics/46983/the-evolving-use-of-neoadjuvant-treatment-paradigms-in-gynecologic-malignancies-early-insights-into-pharmacodynamic-and-clinical-outcomes/magazine The Evolving Use of Neoadjuvant Treatment Paradigms in Gynecologic Malignancies: Early Insights... Nearly all gynecologic cancers are treated with a multimodality therapeutic approach with surgery, systemic therapy, and sometimes radiotherapy with efficacy... https://www.scirp.org/journal/paperinformation?paperid=36586 Sphincter Saving Surgeries for Locally Advanced Low Rectal Cancer after Neoadjuvant Chemoradiation Background: Rectal cancer accounts for the largest distribution within one anatomical region of the large bowel, with approximately one third of all CRC... https://www.mdanderson.org/newsroom/archived-news/brca1-gene-mutation-associated-with-neoadjuvant-chemotherapy.h00-158675001.html ARCHIVED: BRCA1 Gene Mutation Associated with Neoadjuvant Chemotherapy | UT MD Anderson brca1 gene associated with neoadjuvant chemotherapy archived mutation https://pmc.ncbi.nlm.nih.gov/articles/PMC4329780/ Placement of Radiopaque Clips for Tumor Localization in Patients Undergoing Neoadjuvant... The objective of this study was to determine whether patients with breast cancer who received breast-conservation therapy after neoadjuvant chemotherapy had... in patients placement radiopaque clips https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1107307/full Frontiers | Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and... Background: Following the increased survival of patients with metastatic melanoma thanks to immunotherapy and targeted therapy, neoadjuvant approaches are be... frontiers neoadjuvant plus combined sequenced https://www.southampton.ac.uk/research/projects/predicting-response-to-neoadjuvant-therapy-from-pre-treatment-biopsies-in Predicting response to neoadjuvant therapy from pre-treatment biopsies in oesophageal... Predicting response to neoadjuvant therapy from pre-treatment biopsies in oesophageal adenocarcinoma. neoadjuvant therapy pre treatment predicting response https://www.aacr.org/patients-caregivers/progress-against-cancer/nivolumab-approved-for-neoadjuvant-and-adjuvant-treatment-of-non-small-cell-lung-cancer/ Nivolumab Approved for Neoadjuvant and Adjuvant Treatment of NSCLC | Research | AACR Oct 21, 2024 - The immunotherapy nivolumab is now approved as a treatment for certain non-small cell lung cancers before and after surgery. adjuvant treatment nivolumab approved neoadjuvant https://www.mdpi.com/1422-0067/24/14/11297 Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant... Triple-negative breast cancer (TNBC) is particularly challenging due to the weak or absent response to therapeutics and its poor prognosis. The effectiveness... matrix metalloproteinase 9 https://www.mdpi.com/2076-393X/12/9/958/notes Vaccines | Free Full-Text | An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for... https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1115422/full Frontiers | Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell... Primary squamous cell carcinoma of the breast is a rare subtype of carcinoma of chemosis for which there is no effective chemotherapy regimen. Breast squamou... case report https://www.aacr.org/about-the-aacr/newsroom/news-releases/single-cell-spatial-analysis-may-help-predict-response-to-neoadjuvant-immunotherapy-in-triple-negative-breast-cancer/ Single-cell Spatial Analysis May Help Predict Response to Neoadjuvant Immunotherapy in... Dec 7, 2021 - A next-generation technology that allows the study of protein expression at the single-cell level and the location of the cells within the tumor... single cell spatial analysis https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/publications/2026/tracking-response-to-neoadjuvant-systemic-therapy-through-circulating-tumor-dna-analysis-in-breast-cancer Tracking Response to Neoadjuvant Systemic Therapy Through Circulating Tumor DNA Analysis in Breast... Tracking Response to Neoadjuvant Systemic Therapy Through Circulating Tumor DNA Analysis in Breast Cancer circulating tumor dna https://www.elsevier.es/en-revista-cirugia-espanola-english-edition--436-pdf-S2173507719302273 Direct-to-implant breast reconstruction after neoadjuvant chemotherapy: a safe option? direct to implant breast reconstruction neoadjuvant chemotherapy https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.740427/full Frontiers | TMB and TCR Are Correlated Indicators Predictive of the Efficacy of Neoadjuvant... Immune characteristics were reported correlated to benefit of neoadjuvant chemotherapy (NAC) in breast cancer, yet integration of comprehensive genomic alter... https://www.businesswire.com/news/home/20260312182084/en/Personalis-Announces-New-Publication-Advancing-Neoadjuvant-Treatment-Monitoring-in-Breast-Cancer-with-NeXT-Personal Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer... Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of the PREDICT-DNA study in the Journa... new publication personalis announces advancing https://www.spandidos-publications.com/10.3892/ol.2026.15619?text=fulltext Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with vascular invasion: A... Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. hepatocellular carcinoma vascular invasion neoadjuvant radiotherapy resectable https://www.spandidos-publications.com/10.3892/wasj.2021.140 Optimal time to surgery following neoadjuvant chemotherapy and its effect on the survival of... Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology. https://www.spandidos-publications.com/10.3892/mmr_00000190/abstract Excision-repair cross-complementing 1 predicts response to cisplatin-based neoadjuvant... Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery. excision repair cross 1 https://www.frontiersin.org/research-topics/20879/neoadjuvant-therapy-in-rectal-cancer-response-prediction-and-organ-preservation-strategies/magazine Neoadjuvant Therapy in Rectal Cancer: Response Prediction and Organ Preservation Strategies |... The management of rectal cancer has been changing during the last few years. Rates of local control and distant relapses have been improving, and rates of... neoadjuvant therapy rectal cancer https://utswmed.org/medblog/clinical-trial-early-breast-cancer/ Patient benefits from neoadjuvant breast cancer clinical trials | Cancer | UT Southwestern Medical... Breast cancer clinical trials are not experiments. Rather, they are options for women with breast cancer to receive the gold standard of cancer care paired... cancer clinical trials patient benefits ut southwestern neoadjuvant breast https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1239451/full Frontiers | Evaluation of the efficacy and surgical-related safety of neoadjuvant... Background: The emergence of immune checkpoint inhibitors (ICIs) has brought about a paradigm shift in the treatment landscape of non-small cell lung cancer ... of the frontiers evaluation efficacy surgical https://www.mdpi.com/2072-6643/13/12/4471 Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy... Background: Radical cystectomy (RC) is the standard treatment for muscle invasive bladder cancer (MIBC). Neoadjuvant chemotherapy (NAC) is associated with... due to neoadjuvant chemotherapy nutritional status impairment https://www.elsevier.es/en-revista-gastroenterologia-hepatologia-english-edition--382-pdf-S2444382422000979 Neoadjuvant combined strategy to surgery based on chemoembolization and lenvatinib in... based on neoadjuvant combined strategy surgery https://finviz.com/news/197123/ideaya-biosciences-announces-positive-phase-2-data-for-darovasertib-in-the-neoadjuvant-setting-of-primary-uveal-melanoma-in-a-proffered-paper-oral-presentation-at-esmo-2025 IDEAYA Biosciences Announces Positive Phase 2 Data for Darovasertib in the Neoadjuvant Setting of... Stock screener for investors and traders, financial visualizations. https://pmc.ncbi.nlm.nih.gov/articles/PMC12912743/ Locally advanced prostate cancer treated with neoadjuvant therapy combined with surgery: a... Recent data from clinical trials have shown that neoadjuvant therapies significantly improve the pathological outcomes of prostate cancer patients. This study... advanced prostate cancer neoadjuvant therapy locally treated https://www.spandidos-publications.com/10.3892/ol.2012.1004/abstract Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor... Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. complete response https://www.spandidos-publications.com/10.3892/etm.2013.1289/abstract Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine. in patients stage iii https://www.elsevier.es/en-revista-revista-espanola-medicina-nuclear-e-425-articulo-patients-with-initial-nodal-involvement-S2253808922000386 Patients with initial nodal involvement due to breast cancer who have received neoadjuvant... ObjectiveTo study the feasibility and usefulness of ultrasound-guided pre-chemotherapy marking of https://www.elsevier.es/en-revista-cirugia-espanola-english-edition--436-articulo-neoadjuvant-therapy-watch-wait-strategy-S2173507726000451 Neoadjuvant therapy and the Watch and Wait strategy in rectal cancer diagnosed after sex... Social changes and advances in health care have increased the number of sex reassignment surgeries (SRSs) in our hospitals. In this context, these https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1096571/full Frontiers | Prediction of clinical response to neoadjuvant therapy in advanced breast cancer by... Neoadjuvant therapy (NAT) is the preferred treatment for advanced breast cancer nowadays. The early prediction of its responses is important for personalized... https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.816444/full Frontiers | Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of... Muscle-invasive bladder cancer (MIBC) is an aggressive disease requiring active management. Neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC... disease management frontiers clinical complete responders https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1086480/full Frontiers | Evolution and clinical significance of HER2-low status after neoadjuvant therapy for... Abstract Background The emergence of HER2 antibody-drug conjugates provides new treatment decisions for breast cancer patients, especially those with HER2-lo... https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/black-and-white-women-who-received-neoadjuvant-therapy Black and white women who received neoadjuvant therapy were equally likely to have pathologic... Analysis of data from the I-SPY 2 clinical trial showed that race did not significantly affect several key measures of breast cancer treatment outcomes,... black and white https://www.elsevier.es/en-revista-cirugia-espanola-english-edition--436-pdf-S2173507724000140 Neoadjuvant therapy, cytoreductive surgery and HIPEC in locally advanced colon cancer: Are we ready... https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1507281/full Frontiers | Efficacy of anlotinib and chemotherapy combination as neoadjuvant therapy in the... Pulmonary arterial intimal sarcoma (PAIS) is a rare malignant mesenchymal tumor often associated with an unfavorable prognosis and lacks a standardized treat... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-01113 Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer - NCI Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer non small cell lung cancer adjuvant treatment https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-01113&r=1 Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer - NCI Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer non small cell lung cancer adjuvant treatment https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1504917/full Frontiers | Efficacy and safety of neoadjuvant systemic therapy in resectable hepatocellular... BackgroundNeoadjuvant systemic therapy has been shown to benefit patients with solid tumors such as breast cancer and colorectal cancer, but its application ... efficacy and safety systemic therapy frontiers https://www.mdanderson.org/newsroom/archived-news/first-study-of-neoadjuvant-use-of-parp-inhibitor-shows-promise-for-early-stage-BRCA-positive-breast-cancer-patients.h00-159224145.html ARCHIVED: First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA+... In a small Phase II study of early-stage breast cancer patients with BRCA1/2 mutations, researchers at The University of Texas MD Anderson Cancer Center found... https://www.elsevier.es/en-revista-actas-urologicas-espanolas-english-392-articulo-oncological-outcomes-patients-with-node-S217357862500006X Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and... IntroductionUntil recently there was no recommended adjuvant therapy for patients with lymph nodes https://www.mdanderson.org/newsroom/archived-news/breast-biopsies-after-neoadjuvant-chemotherapy-accurately-predict-presence-of-residual-breast-cancer.h00-159308568.html ARCHIVED: Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual... Researchers from The University of Texas MD Anderson Cancer Center have identified a standardized protocol that uses image-guided breast biopsies to reliably... neoadjuvant chemotherapy accurately predict archived breast biopsies https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.877825/full Frontiers | Predicting Pathological Complete Response in Neoadjuvant Dual Blockade With Trastuzumab... Background: Dual-targeted therapy is the standard treatment for human epidermal growth factor receptor 2 (HER2)-positive breast cancer, and effective biomark... complete response frontiers predicting pathological https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.998620/full Frontiers | Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or... Background: Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy (nICT) or chemoradiotherapy (nICRT) has been tested in resectable esopha... immune checkpoint inhibitor frontiers neoadjuvant combination chemotherapy https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-06635&r=1 Belzutifan or Pembrolizumab Alone versus in Combination for Neoadjuvant Treatment of Clear Cell... Belzutifan or Pembrolizumab Alone versus in Combination for Neoadjuvant Treatment of Clear Cell Renal Cell Cancer, BLAZE Trial https://www.mayo.edu/research/clinical-trials/cls-20146654 A Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant... Learn more about services at Mayo Clinic. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neoadjuvant-and-adjuvant-pembrolizumab-resectable-locally-advanced-head-and-neck FDA approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck... On June 12, 2025, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for adults with resectable locally advanced head and neck squamous... https://www.nyp.org/advances/video/cancer/dr-nasser-altorki-neoadjuvant-immunotherapy-and-radiation-boosts-response-in-nsclc Dr. Nasser Altorki: Neoadjuvant immunotherapy and radiation boosts response in NSCLC | NYP Dr. Nasser Altorki: Neoadjuvant immunotherapy and radiation boosts response in NSCLC https://pmc.ncbi.nlm.nih.gov/articles/PMC9982353/ The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients... The aim of the study was to investigate the effects of body mass index (BMI) on the response to neoadjuvant chemotherapy (NACT) in Turkish patients with local... https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1511691/full Frontiers | CT-based radiomics for prediction of response to neoadjuvant immunochemotherapy in... BackgroundIn order to investigate the value of radiomic features derived from enhanced computed tomography (CT) for assessment of therapeutic efficacy in pat... https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1468279/full Frontiers | A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy,... PurposeThe management of rectal adenocarcinoma has evolved during the last decade, shifting from a conventional neoadjuvant chemoradiotherapy, surgery, and a... phase 3 trial https://www.mayo.edu/research/clinical-trials/cls-20558653 Surgery With Or Without Neoadjuvant Chemotherapy In High Risk RetroPeritoneal Sarcoma - Mayo Clinic Learn more about services at Mayo Clinic. https://finviz.com/news/159743/ideaya-biosciences-announces-positive-interim-phase-2-data-for-darovasertib-in-the-neoadjuvant-setting-of-primary-uveal-melanoma IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib in the Neoadjuvant... Stock screener for investors and traders, financial visualizations. https://www.aacr.org/about-the-aacr/newsroom/news-releases/neoadjuvant-nivolumab-plus-chemotherapy-increased-pathological-complete-response-rate-in-checkmate-816-lung-cancer-trial/ Neoadjuvant Nivolumab plus Chemotherapy Increased Pathological Complete Response Rate in... Adding nivolumab (Opdivo) to chemotherapy as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC) produced significant... complete response neoadjuvant nivolumab plus chemotherapy https://www.spandidos-publications.com/10.3892/ol.2026.15619 Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with vascular invasion: A... Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. hepatocellular carcinoma vascular invasion neoadjuvant radiotherapy resectable https://www.spandidos-publications.com/10.3892/ol.2023.13741/abstract Longer interval between neoadjuvant chemoradiotherapy and surgery is associated with improved... Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. associated with longer interval neoadjuvant chemoradiotherapy https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neoadjuvantadjuvant-nivolumab-resectable-non-small-cell-lung-cancer FDA approves neoadjuvant/adjuvant nivolumab for resectable non-small cell lung cancer | FDA On October 3, 2024, the FDA approved neoadjuvant/adjuvant nivolumab with platinum-doublet chemotherapy for resectable non-small cell lung cancer. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.901494/full Frontiers | Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell... Background: It remains uncertain whether neoadjuvant immune checkpoint inhibitor (nICI) is superior to neoadjuvant chemotherapy (nCT) in resectable non-small... frontiers neoadjuvant immunotherapy chemotherapy resectable https://www.spandidos-publications.com/10.3892/or.2018.6366?text=fulltext let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. https://www.spandidos-publications.com/10.3892/or.2018.6366/abstract let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. https://www.sciencedaily.com/releases/2011/08/110823115425.htm Clinical trial shows benefit to adding avastin to neoadjuvant chemotherapy in breast cancer... Amid the controversy surrounding the Food and Drug Administration's ruling that Avastin should no longer be used to treat metastatic breast cancer, a new... clinical trial https://www.elsevier.es/es-revista-revista-senologia-patologia-mamaria--131-pdf-S0214158224000410 Is neoadjuvant treatment indicated in triple negative cT1N0 breast cancer? triple negative neoadjuvant treatment indicated breast https://elifesciences.org/articles/101583/figures Figures and data in Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus... Neoadjuvant SBRT with dalpiciclib and exemestane resulted in a 16.7% RCB 0-I rate and a 91.7% ORR, with acceptable toxicities in HR-positive, HER2-negative... https://pmc.ncbi.nlm.nih.gov/articles/PMC3680942/ Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast... Presence of disseminated tumor cells (DTCs) in bone marrow (BM) and circulating tumor cells (CTC) in peripheral blood (PB) predicts reduced survival in early... tumor cells https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1533651/full Frontiers | Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer:... BackgroundNeoadjuvant immunotherapy (NIT) is a rapidly emerging paradigm for advanced resectable non-small cell lung cancer (NSCLC). However, there is no bib... insight into https://elifesciences.org/reviewed-preprints/95988v1 Unveiling neoadjuvant chemotherapy-induced immune landscape remodeling and metabolic reprogramming... neoadjuvant chemotherapy landscape remodeling unveiling induced immune https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1518217/full Frontiers | Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint... BackgroundAlthough immune checkpoint inhibitors (ICIs) and anti-angiogenic drugs have demonstrated effectiveness in treating advanced gastric cancer (GC), th... neoadjuvant chemotherapy frontiers combined antiangiogenic immune https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1479263/full Frontiers | Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with... BackgroundTreatment of locally advanced unresectable non-small cell lung cancer (NSCLC) is a significant challenge, especially for patients with IIIA/IIIB NS... efficacy and safety in patients frontiers https://www.spandidos-publications.com/10.3892/or.2014.3025/abstract Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using... Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT03732677&r=1 Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in... Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC durvalumab gemcitabine cisplatin neoadjuvant treatment https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1100427/full Frontiers | Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer... Most locally advanced breast cancer patients undergo pre-surgery treatment known as neoadjuvant chemotherapy (NAC). The purpose of NAC is to reduce the tumor... neoadjuvant chemotherapy frontiers editorial recent advancements https://www.mayo.edu/research/clinical-trials/cls-20438440 Eliminating Breast Cancer Surgery in Exceptional Responders with Neoadjuvant Systemic Therapy -... Learn more about services at Mayo Clinic. breast cancer surgery https://www.mdpi.com/2072-6694/14/18/4436 Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy This study tested the hypothesis that a change in the apparent diffusion coefficient (ADC) measured in diffusion-weighted MRI (DWI) is an independent imaging... diffusion weighted mri complete response predicting https://www.wikidata.org/wiki/Q78785374 Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy... scientific article published on 01 January 2003 in patients skeletal osteosarcoma https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1125021/full Frontiers | BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant... Background: About 15% of Triple-Negative-Breast-Cancer (TNBC) present silencing of the BRCA1 promoter methylation and are assumed to be Homologous Recombinat... triple negative breast cancers frontiers brca1 methylated https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1066007/full Frontiers | Review of the status of neoadjuvant therapy in HER2-positive breast cancer PurposeThe development of human epidermal growth factor receptor 2 (HER2)-directed therapies has revolutionised the treatment of HER2-positive breast cancer.... of the neoadjuvant therapy https://pmc.ncbi.nlm.nih.gov/articles/PMC5095077/ Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in... TPF (docetaxel, cisplatin, fluorouracil) is the standard chemotherapy used for induction in locally advanced head and neck squamous cell carcinoma (LAHNSCC).... https://elifesciences.org/articles/101583/peer-reviews Peer review in Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus... Neoadjuvant SBRT with dalpiciclib and exemestane resulted in a 16.7% RCB 0-I rate and a 91.7% ORR, with acceptable toxicities in HR-positive, HER2-negative... efficacy and safety https://www.nice.org.uk/guidance/ta876 Overview | Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung... Evidence-based recommendations on nivolumab (Opdivo) with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer in adults